Epcoritamab (CD3E;MS4A1/CD20) Antibody, Monoclonal
| Code | Size | Price |
|---|
| PSI-10-978-0.1mg | 0.1mg | £657.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: IgG4-kappa-lambda
Antibody Clonality: Recombinant Antibody
Regulatory Status: RUO
Shipping:
blue ice
Storage:
Store at -80˚C
Documents
Further Information
Additional Names:
GEN3013
Background:
Epcoritamab (DuoBody?-CD3xCD20) is a proprietary bispecific antibody created using Genmab?s DuoBody technology.It targets CD20 on the B-cells,a clinically well-validated target that is expressed in a wide variety of B-cell malignancies.Epcoritamab is currently under investigation in a Phase I/II study for multiple hematological B cell malignancies.
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Homo sapiens,Chimeric / CD3E;MS4A1/CD20 [Homo sapiens]
NCBI Organism:
homo sapiens
Purification:
>95%
Research Area:
Drug Analogues
Source:
CHO cells
User NOte:
Optimal dilutions for each application to be determined by the researcher.